BNTC
Benitec Biopharma Ltd
9.60$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -21.1% | -29.8% | +248.1% | +31.7% | +15.0% | +33.1% | -5.3% | -3.6% | +98.6% | -1.9% | -2.3% | |
| – | -21.3% | -30.9% | +259.7% | +32.2% | +15.2% | +32.1% | -5.3% | -3.5% | +99.4% | -1.9% | -2.3% | |
| – | -21.2% | -30.6% | +259.7% | +33.4% | +15.4% | +32.3% | -5.6% | -3.3% | +99.8% | -2.1% | -2.6% | |
| – | -21.2% | -30.6% | +259.7% | +33.4% | +15.4% | +32.3% | -5.6% | -3.3% | +99.8% | -2.1% | -2.6% | |
| – | +0.0% | +0.0% | +332.1% | -98.3% | -50.0% | +50.0% | +1,000.0% | -78.8% | +1,757.1% | -97.7% | – | |
| – | +7.7% | -100.0% | +5,249,900.0% | – | – | – | – | – | – | – | – | |
| – | +24.0% | -40.5% | +41.8% | -7.4% | -31.9% | +144.3% | -69.9% | +5.7% | +36.7% | +10.5% | +52.9% | |
| – | +26.7% | -40.2% | +43.3% | -7.5% | -32.2% | +127.5% | -74.4% | +12.4% | +38.3% | +16.9% | +63.2% | |
| – | +2.1% | +2.1% | -2.7% | -25.7% | -35.1% | +152.6% | +2.3% | +16.9% | +13.0% | +3.0% | +2.9% | |
| – | +71.4% | -68.9% | +65.8% | -33.2% | -34.3% | -27.0% | -53.6% | +34.8% | +274.9% | -37.5% | – | |
| – | -30.7% | -25.7% | +310.9% | +35.8% | +18.3% | +28.5% | -0.3% | -3.8% | +100.2% | -2.2% | -3.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.4% | +1.6% | -3.6% | +5.5% | +107.4% | +74.9% | -6.2% | +14.7% | +10.7% | +7.4% | -5.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.